Antithrombotics are vital in the treatment and prevention of an array ... US FDA warnings and has created a market for novel antithrombotic drugs that do not succumb to genetic variants.

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of patients with cardiovascular disease. The improvement of our knowledge on the ...

Antithrombotic therapy presents a unique challenge for patients considering some Alzheimer's drugs. In their Viewpoint, the authors note that in approving lecanemab, the FDA did not advise ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...